Global Emergency And Critical Care

A Rare Case of Mortal Metformin Intoxication [Glob Emerg Crit Care]
Glob Emerg Crit Care. 2022; 1(1): 28-30

A Rare Case of Mortal Metformin Intoxication

Adem Az, Tarık Akdemir
University of Health Sciences, Haseki Training and Research Hospital, Department of Emergency Medicine, Istanbul

Metformin is the first-line oral antidiabetic for the treatment of type 2 diabetes mellitus (DM). Its major toxicity is lactic acidosis (LA). Metformin‐induced LA (MILA) rarely develops in the absence of acute overdose. However, LA is the most serious complication of metformin intoxication, and MILA is associated with high mortality rates. We presented a comparative evaluation of a mortal MILA case with the literature. A 47-year-old woman with type 2 DM and using metformin, admitted to the emergency department with abdominal pain and vomiting that started 4 hours after taking 60 gr metformin for suicide. There was no abnormality on her initial hemogram, biochemical profile, and coagulation findings. However, her arterial blood gas analysis on admission was remarkable for pH: 7.025 and lactate: 20.32 mmol/L. Hemodialysis was planned rapidly in the patient with high anion gap metabolic acidosis. Despite the aggressive therapy, the patient developed ventricular fibrillation and then cardiac arrest and died in the 4th hour of her admission to the emergency department. In acute and high-dose metformin intoxication, metabolic acidosis can develop rapidly. Hemodialysis therapy should not be delayed, especially in cases with MILA. It should be remembered that these cases are mortal despite aggressive treatment.

Keywords: Hemodialysis, lactic acidosis, metformin, mortality, suicide


Adem Az, Tarık Akdemir. A Rare Case of Mortal Metformin Intoxication. Glob Emerg Crit Care. 2022; 1(1): 28-30

Corresponding Author: Adem Az, Türkiye


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar